How Much Upside is Left in MiMedx (MDXG)? Wall Street Analysts Think 37.12%

Core Viewpoint - MiMedx (MDXG) has shown a significant price increase of 61.5% over the past four weeks, with a mean price target of $12.67 indicating a potential upside of 37.1$9.24 [1] Price Targets - The average price target consists of six estimates ranging from a low of $11 to a high of$16, with a standard deviation of $1.75, suggesting a variability in analyst estimates [2] - The lowest estimate indicates a potential increase of 19.1%, while the highest suggests a 73.2% upside [2] - A low standard deviation indicates a high degree of agreement among analysts regarding the stock's price movement [7] Analyst Sentiment - Analysts have shown increasing optimism about MDXG's earnings prospects, as evidenced by a strong consensus in revising EPS estimates higher [9] - Over the last 30 days, two estimates have been revised upward, leading to a 13.5% increase in the Zacks Consensus Estimate [10] - MDXG holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [11] Caution on Price Targets - Solely relying on consensus price targets for investment decisions may not be prudent, as empirical research indicates that such targets often mislead investors [5][8] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [6]